Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Macro Group Pharmaceuticals (Macro Capital) Co Operating Margin %?
Macro Group Pharmaceuticals (Macro Capital) CoCAI:MCRO -0.66%38 Operating Margin % is 15.90% as of Mar. 2026, which is 54% below its 10-year median of 34.35. GuruFocus rates CAI:MCRO with a GF Score™ of 38/100. The stock has 2 warning signs investors should review. Among 1,957 Consumer Packaged Goods companies, Macro Group Pharmaceuticals (Macro Capital) Co ranks better than 87.33% on this metric.
CAI:MCRO'
s Operating Margin % Range Over the Past 10 Years
Min: 16.7 Med: 34.35 Max: 42.88
Current: 16.7
CAI:MCRO's Operating Margin % is ranked better than 87.33% of 1957
companies
in the Consumer Packaged Goods industry
Industry Median: 5.43
vs CAI:MCRO: 16.70
Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Macro Group Pharmaceuticals (Macro Capital) Co Operating Margin % Related Terms
Macro Group Pharmaceuticals (Macro Capital) Co Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Macro Group Pharmaceuticals (Macro Capital) Co Operating Margin % Chart
Macro Group Pharmaceuticals (Macro Capital) Co Annual Data
Trend
Dec20
Dec21
Dec22
Operating Margin %
42.88
34.35
32.55
Macro Group Pharmaceuticals (Macro Capital) Co Quarterly Data
CAI:MCRO vs PG, CL, KVUE: Operating Margin % Comparison
For the Household & Personal Products subindustry, Macro Group Pharmaceuticals (Macro Capital) Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Macro Group Pharmaceuticals (Macro Capital) Co Operating Margin % vs Consumer Packaged Goods Industry
Macro Group Pharmaceuticals (Macro Capital) Co Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) has a Operating Margin % of 15.90% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Macro Group Pharmaceuticals (Macro Capital) Co and its competitors. This is 54% below median its historical median of 34.35. Over the past decade, Macro Group Pharmaceuticals (Macro Capital) Co's Operating Margin % has ranged from 16.70 to 42.88. According to the industry distribution chart, Macro Group Pharmaceuticals (Macro Capital) Co ranks #248 out of 1957 companies in the Consumer Packaged Goods industry, placing it in the top 12.7%.
Is Macro Group Pharmaceuticals (Macro Capital) Co's Operating Margin % too high?
Macro Group Pharmaceuticals (Macro Capital) Co's current Operating Margin % of 15.90% is 54% below median its 10-year median of 34.35. Over the past 10 years, this metric has ranged from a low of 16.70 to a high of 42.88. The Consumer Packaged Goods industry median Operating Margin % is 5.43. Macro Group Pharmaceuticals (Macro Capital) Co's value of 15.90% is 192.8% above this industry median. Based on the distribution chart, Macro Group Pharmaceuticals (Macro Capital) Co ranks #248 out of 1957 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Macro Group Pharmaceuticals (Macro Capital) Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Macro Group Pharmaceuticals (Macro Capital) Co's Operating Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Macro Group Pharmaceuticals (Macro Capital) Co ranks #248 out of 1957 companies for Operating Margin %. This places Macro Group Pharmaceuticals (Macro Capital) Co in the top 13% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 5.43. Macro Group Pharmaceuticals (Macro Capital) Co's value of 15.90% is 192.8% above this benchmark. Historically, Macro Group Pharmaceuticals (Macro Capital) Co's own Operating Margin % has ranged from 16.70 to 42.88 over the past decade. While the company's 10-year median is 34.35 vs. the industry median of 5.43, Macro Group Pharmaceuticals (Macro Capital) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Consumer Packaged Goods company?
The median Operating Margin % among Consumer Packaged Goods companies is 5.43, based on 1,957 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Macro Group Pharmaceuticals (Macro Capital) Co's current Operating Margin % of 15.90% is 192.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Macro Group Pharmaceuticals (Macro Capital) Co and its competitors. For the Consumer Packaged Goods industry, the median Operating Margin % is 5.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Macro Group Pharmaceuticals (Macro Capital) Co's current Operating Margin % is 15.90%, which is 54% below median its own 10-year median of 34.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Macro Group Pharmaceuticals (Macro Capital) Co stock overvalued right now?
Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) has a current Operating Margin % of 15.90%. The current Operating Margin % is 15.90%, which is 54% below median its 10-year median of 34.35 and 192.8% above the Consumer Packaged Goods industry median of 5.43. Macro Group Pharmaceuticals (Macro Capital) Co's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO), the current Operating Margin % is 15.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Macro Group Pharmaceuticals (Macro Capital) Co is principally engaged in the manufacture and sale of cosmeceutical and ventured into nutraceutical products.
38GF Score
Get the complete analysis for CAI:MCRO
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:MCRO has been successfully added to your 
